The Analyst Verdict: Enovix In The Eyes Of 8 Experts
The Analyst Verdict: Enovix In The Eyes Of 8 Experts
分析師意見：Enovix在8位專家眼中
An in-depth analysis of recent...During the last three months, 8 analysts shared their evaluations of Enovix (NASDAQ:ENVX), revealing diverse outlooks from bullish to bearish.
在過去的三個月裏，8位分析師對Enovix（納斯達克代碼：ENVX）進行了評估，展示了從看好到看淡的不同觀點。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他們最近的評級，展示了過去30天內的情緒演變並與之前的幾個月進行了比較。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $22.62, with a high estimate of $36.00 and a low estimate of $14.00. This upward trend is apparent, with the current average reflecting a 6.25% increase from the previous average price target of $21.29.
總資產回報率（ROA）：Enovix的ROA低於行業平均水平，表明從資產中獲取最大回報方面存在挑戰。公司ROA爲-23.22％，可能會面臨實現最佳財務績效方面的障礙。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級：更深入的了解
登入免費觀看全文
登入/註冊